Rep. Andy Biggs

Maddy summaryHR 2183 limits funding for the U.S. Department of the Interior's Central Hazardous Materials Fund to $10,010,000 for fiscal year 2024. This bill directly affects the Interior Department's hazardous materials program by restricting its available budget for that year. The key provision is a strict spending cap that prevents the use of funds exceeding this amount for the specified program. The bill does not change program policies or create new requirements - only sets a maximum funding level.

Maddy summaryHR 2191 blocks all funding for the Environmental Protection Agency's Hazardous Waste Electronic Manifest System in fiscal year 2024 by setting its available funds to $0. This bill directly affects the EPA's ability to operate this specific system, which tracks hazardous waste shipments electronically. The key mechanism is a strict prohibition on appropriating any funds for this system during FY2024, effectively halting its operation unless Congress passes new funding. As a procedural funding limitation, it does not change environmental regulations but prevents the system from functioning without new appropriations.

Maddy summaryHR 2241 sets a funding limit of $3,503,000 for the U.S. Department of Agriculture's Hazardous Materials Management program during fiscal year 2024. This bill directly restricts the amount of money the USDA can spend on managing hazardous materials under this specific program. It prevents the program from using funds exceeding this cap, applying only to the designated hazardous materials management activities within the USDA for that fiscal year.

This bill limits FY2024 funding for the Food and Drug Administration (FDA) Innovation Account, which the FDA uses to implement provisions of the 21st Century Cures Act relating to the development of medical products.

Maddy summaryHR 2296 sets a spending limit of $11,788,000 for building and facility projects at the Food and Drug Administration (FDA) and an unspecified "Related Agency" during fiscal year 2024. This bill directly restricts the budget available for infrastructure improvements at these two entities, capping all allocated funds for this purpose. The provision applies to all existing and future funding designated for these specific projects in the 2024 budget cycle. It does not alter FDA operations or regulations, only the financial allocation for physical facilities.

Maddy summaryThis bill sets a spending cap of $5.58 billion for the Food and Drug Administration (FDA) and related agencies within the Department of Health and Human Services (HHS) for fiscal year 2024. It directly affects the FDA's budget authority by restricting the total funds it can access during the fiscal year. The key provision is a hard limit on available funds, preventing the use of any amount exceeding $5,584,965,000. This is a straightforward budgetary restriction with no additional policy mechanisms or program changes.

Right to Try Clarification Act This bill specifies that investigational drugs that are provided via the Right to Try pathway are exempt from restrictions that would otherwise apply under the Controlled Substances Act (e.g., restrictions on the use or possession of schedule I controlled substances). The Right to Try pathway allows drug manufacturers to provide certain investigational drugs for which a Phase I clinical trial has been completed, but that have not yet received approval from the Food and Drug Administration, directly to individuals who have imminently life-threatening diseases or conditions and who have exhausted other treatment options and are unable to participate in clinical trials.

Maddy summaryThe Safe Students Act (HR 2502) repeals the Gun-Free School Zones Act of 1990, which had prohibited possessing firearms in federally designated school zones under federal law. It also amends related sections of Title 18 (U.S. Code) to remove references to the repealed law and adjust section numbering. This bill does not establish a new federal rule for school zones; it solely eliminates the existing federal prohibition on firearms in school zones. The repeal means the federal government would no longer enforce this specific ban, though state laws may continue to regulate firearms in schools.

Protect Against School Shootings Act or the PASS Act This bill broadens the authority for certain individuals to carry concealed firearms in a school zone. Specifically, the bill exempts the following categories of individuals from the federal prohibition on possessing (or discharging) a firearm in a school zone: certain active and retired law enforcement officers who are authorized to carry concealed firearms under federal law, and individuals who are allowed to carry concealed firearms under the law of a state.

Maddy summaryHR 1768, the NIH Reform Act, reorganizes the National Institutes of Health (NIH) by splitting the existing "National Institute of Allergy and Infectious Diseases" into three distinct institutes: the National Institute of Allergic Diseases, the National Institute of Infectious Diseases, and the National Institute of Immunologic Diseases. The bill updates titles, responsibilities, and leadership structures in the Public Health Service Act, including requiring presidential appointments with Senate confirmation for directors of the new institutes, each serving 5-year terms (with one possible reappointment). It mandates a transition period where the NIH Director oversees the new institutes until their directors are appointed, and updates all references to the former institute in federal law. This change directly affects NIH’s internal structure, leadership appointments, and administrative documentation, without altering research funding or policy priorities.